Clinical Trial Update: Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD). [NA]

View source ↗

Summary

A completed clinical trial evaluating the accuracy of continuous glucose monitoring in patients with end-stage renal disease on intermittent hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Virginia | Conditions: Diabetes, Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2022-12-21